- Home
- TECH vs DRRX Comparison
TECH vs DRRX Comparison
Compare TECH & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- DRRX
- Stock Information
- Founded
- TECH 1976
- DRRX 1998
- Country
- TECH United States
- DRRX United States
- Employees
- TECH N/A
- DRRX N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- TECH Health Care
- DRRX Health Care
- Exchange
- TECH Nasdaq
- DRRX Nasdaq
- Market Cap
- TECH 8.0B
- DRRX N/A
- IPO Year
- TECH 1989
- DRRX 2000
- Fundamental
- Price
- TECH $48.10
- DRRX $0.75
- Analyst Decision
- TECH Buy
- DRRX Hold
- Analyst Count
- TECH 9
- DRRX 1
- Target Price
- TECH $81.25
- DRRX N/A
- AVG Volume (30 Days)
- TECH 2.2M
- DRRX 46.2K
- Earning Date
- TECH 05-07-2025
- DRRX 05-12-2025
- Dividend Yield
- TECH 0.63%
- DRRX N/A
- EPS Growth
- TECH N/A
- DRRX N/A
- EPS
- TECH 0.98
- DRRX N/A
- Revenue
- TECH $1,196,016,000.00
- DRRX $2,031,000.00
- Revenue This Year
- TECH $8.19
- DRRX N/A
- Revenue Next Year
- TECH $8.85
- DRRX $935.93
- P/E Ratio
- TECH $49.09
- DRRX N/A
- Revenue Growth
- TECH 4.46
- DRRX N/A
- 52 Week Low
- TECH $46.44
- DRRX $0.70
- 52 Week High
- TECH $85.57
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- TECH 33.97
- DRRX 45.50
- Support Level
- TECH $46.44
- DRRX $0.79
- Resistance Level
- TECH $53.00
- DRRX $0.76
- Average True Range (ATR)
- TECH 3.30
- DRRX 0.04
- MACD
- TECH -0.27
- DRRX -0.01
- Stochastic Oscillator
- TECH 13.00
- DRRX 41.67
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.